Medium-term Results of the LPS™ System for Segmental Resection of the Distal Femur, a Multicenter Retrospective Study (RESIF)
RESIF
1 other identifier
observational
77
1 country
1
Brief Summary
The reconstruction of the distal femur using modular systems has become increasingly popular over the years, surpassing primary arthrodesis or amputation. Despite the significant advantages of using megaprostheses, complications are not uncommon. Although the Limb Preservation System™ (LPS™, DePuy Synthes; Warsaw, USA) is one of the most widely used megaprostheses in the French market, there is currently no national evaluation of this system, and only two studies have been conducted worldwide. The aim of our study is to present the mid-term survival rates of the LPS™ implant in order to answer three main questions:
- 1.What are the overall outcomes of the LPS™ system in distal femur replacement?
- 2.What factors are associated with a reduced survival rate of the implant?
- 3.What is the cumulative risk of complications according to Henderson's classification?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 13, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedApril 15, 2025
October 1, 2024
9 months
February 13, 2025
April 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LPS stent failure
Failure will be defined as the replacement of the femoral anchorage or amputation.
From enrollment to last consultation
Secondary Outcomes (2)
complications of the LPS stent
From enrollment to last consultation
Surgical revision of the LPS stent
From enrollment to last consultation
Interventions
Reconstruction using the Limb Preservation System™ for segmental resection of the distal femur.
Eligibility Criteria
The institutional databases of university hospitals belonging to the HugOrtho network (Hôpitaux Universitaires du Grand Ouest) will be examined to identify patients who will have undergone reconstruction using the Limb Preservation System™ (LPS™, DePuy Synthes; Warsaw, USA) for segmental resection of the distal femur, regardless of the indication.
You may qualify if:
- \- Patients who underwent distal femoral reconstruction using the LPS system.
You may not qualify if:
- Lost to follow-up before 3 months.
- Associated tibial reconstruction using the LPS system.
- Total femoral reconstruction using the LPS system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Brest
Brest, 29609, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 13, 2025
First Posted
April 15, 2025
Study Start
November 1, 2024
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
April 15, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning three years and ending fifteen years following the final study report completion
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement
All collected data that underlie results in a publication